AN-019

SKU: orb1701202

Description

AN-019 (NRC-019) is a research compound that inhibits the Bcr-Abl kinase, making it a candidate for studying chronic myelogenous leukemia (CML) and breast cancer. Its activity has been investigated in cellular assays and animal models to evaluate its potential therapeutic effects.

Research Area

Cardiovascular Research, Signal Transduction

Key Properties

• CAS Number: 879507-25-2
• MW: 517.43
• Purity: 98.99%
• Formula: C₂₅H₁₇F₆N₅O
• SMILES: O=C(NC1=CC=C(C(=C1)NC=2N=CC=C(N2)C3=CN=CC=C3)C)C=4C=C(C=C(C4)C(F)(F)F)C(F)(F)F
• Target: Bcr-Abl

Storage & Handling

• Storage: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

AN019, AN-019, AN 019, Bcr-Abl, BcrAbl, NRC 019, NRC, NRC-AN 019, NRC-AN019, NRC-AN-019, NRC019, NRC-019

Compound Identifiers

PubChem CID

11562629